SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 14, 2003
GENETHERA, INC.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
Florida 0-27237 66-0622463
------- ---------- ----------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
3930 Youngfield Street, Wheat Ridge, Colorado 80033
---------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 303-463-6371
------------
Hand Brand Distribution, Inc.
9845 NE 2nd Avenue
Miami Shores, FL 33138
-----------------------------------------------------------
(Former name or former address, if changed since last report)
Item 4: Changes in registrant's accountant
On September 11, 2003, via e-mail and hard copy, the registrant's auditors
Kantor, Sewell & Oppenheimer, PA terminated the professional relationship. The
registrant is in the process of interviewing and hiring a new auditing firm.
Item 5. Other Events
------------
On July 1, 2003, the registrant filed with the Florida Secretary of State's
office amendments to its articles of incorporation to change the name from Hand
Brand Distribution, Inc. to GeneThera, Inc. and to authorize one hundred million
(100,000,000) shares of common stock and twenty million (20,000,000) shares of
class A preferred stock. Please see attached exhibit Amendments to Articles of
Incorporation filed with Florida Secretary of State.
Item 7. Exhibits and Financials
-----------------------
Exhibit
Number Description
------ -----------
3.1 Certificate of Amendment of the Articles of Incorporation of
Hand Brand Distribution
16 Letter from Accountant
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
GENETHERA, INC.
By: /s/ Tony Milici
-----------------------------------------
Tony Milici, M.D., Ph.D.
Chief Executive Officer